Although the benefit of using NT-proBNP and BNP in the context of HF has been demonstrated and, more recently, expanded to include risk stratification of patients with T2DM, some limitations to its use in clinical practice should be highlighted. Here, NPPB is linked to type 2 diabetes mellitus.